affinity of SERCA by substituting SERCA2a with the higher affinity SERCA2b pump. When phospholamban was also ablated, these double knockouts (DKO) exhibited a dramatic reduction in total SERCA levels, severe hypertrophy, and diastolic dysfunction. We presently examined the role of cardiomyocyte Ca 2ϩ homeostasis in both functional and structural remodeling in these hearts. Despite the low SERCA levels in DKO, we observed near-normal Ca 2ϩ homeostasis with rapid Ca 2ϩ reuptake even at high Ca 2ϩ loads and stimulation frequencies. Well-preserved global Ca 2ϩ homeostasis in DKO was paradoxically associated with marked activation of the Ca 2ϩ -dependent nuclear factor of activated T-cell-calcineurin pathway known to trigger hypertrophy. No activation of the MAP kinase signaling pathway was detected. These findings suggest that local changes in Ca 2ϩ homeostasis may play an important signaling role in DKO, perhaps due to reduced microdomain Ca 2ϩ buffering by SERCA2b. Furthermore, alterations in global Ca 2ϩ homeostasis can also not explain impaired in vivo diastolic function in DKO. Taken together, our results suggest that normalizing global cardiomyocyte Ca 2ϩ homeostasis does not necessarily protect against hypertrophy and heart failure development and that excessively increasing SERCA Ca 2ϩ affinity may be detrimental. content and cellular contractility. SERCA activity is regulated by phospholamban (PLB), which inhibits SERCA by decreasing its apparent Ca 2ϩ affinity. The pivotal role of PLB as an affinity modulator has been explored in a number of transgenic mouse models. Decreasing the affinity of SERCA for cytosolic
Louch WE, Vangheluwe P, Bito V, Raeymaekers L, Wuytack F, Sipido KR. Phospholamban ablation in hearts expressing the high affinity SERCA2b isoform normalizes global Ca 2ϩ homeostasis but not Ca 2ϩ -dependent hypertrophic signaling. Am J Physiol Heart Circ Physiol 302: H2574 -H2582, 2012. First published April 13, 2012 ; doi:10.1152/ajpheart.01166.2011.-Cardiomyocytes from failing hearts exhibit reduced levels of the sarcoplasmic reticulum (SR) Ca 2ϩ -ATPase (SERCA) and/or increased activity of the endogenous SERCA inhibitor phospholamban. The resulting reduction in the Ca 2ϩ affinity of SERCA impairs SR Ca 2ϩ cycling in this condition. We have previously investigated the physiological impact of increasing the Ca 2ϩ affinity of SERCA by substituting SERCA2a with the higher affinity SERCA2b pump. When phospholamban was also ablated, these double knockouts (DKO) exhibited a dramatic reduction in total SERCA levels, severe hypertrophy, and diastolic dysfunction. We presently examined the role of cardiomyocyte Ca 2ϩ homeostasis in both functional and structural remodeling in these hearts. Despite the low SERCA levels in DKO, we observed near-normal Ca 2ϩ homeostasis with rapid Ca 2ϩ reuptake even at high Ca 2ϩ loads and stimulation frequencies. Well-preserved global Ca 2ϩ homeostasis in DKO was paradoxically associated with marked activation of the Ca 2ϩ -dependent nuclear factor of activated T-cell-calcineurin pathway known to trigger hypertrophy. No activation of the MAP kinase signaling pathway was detected. These findings suggest that local changes in Ca 2ϩ homeostasis may play an important signaling role in DKO, perhaps due to reduced microdomain Ca 2ϩ buffering by SERCA2b. Furthermore, alterations in global Ca 2ϩ homeostasis can also not explain impaired in vivo diastolic function in DKO. Taken together, our results suggest that normalizing global cardiomyocyte Ca 2ϩ homeostasis does not necessarily protect against hypertrophy and heart failure development and that excessively increasing SERCA Ca 2ϩ affinity may be detrimental. content and cellular contractility. SERCA activity is regulated by phospholamban (PLB), which inhibits SERCA by decreasing its apparent Ca 2ϩ affinity. The pivotal role of PLB as an affinity modulator has been explored in a number of transgenic mouse models. Decreasing the affinity of SERCA for cytosolic Ca 2ϩ by increasing inhibition from PLB causes decreased cardiac function and heart failure (7, 15, 34, 37) . In contrast, increasing the ratio of the cardiac-specific SERCA isoform (SERCA2a) to PLB improves cardiac function (12, 20, 30, 33) and can alleviate heart failure (8, 22) . However, ablation of PLB does not rescue cardiac dysfunction in all mouse models of heart failure (24, 35) . As well, a mutated form of PLB that cannot inhibit SERCA has been linked to heart failure in humans (11) . Thus the therapeutic potential of increasing the Ca 2ϩ affinity of SERCA is not unambiguous (23) . This issue is particularly relevant since the benefits of SERCA overexpression in heart failure patients are already being examined in an ongoing clinical trial (14) .
Since increasing the Ca 2ϩ affinity of SERCA2a has potential to improve cardiac contractility, it is quite surprising that the heart expresses SERCA2a rather than the ubiquitous Ca 2ϩ pump SERCA2b. Indeed, SERCA2b has a higher Ca 2ϩ affinity but lower maximal turnover rate than SERCA2a and, as could be expected from a housekeeping pump, is normally expressed at low levels also in cardiomyocytes (9, 26) . To address this, we have previously investigated mice in which the SERCA2a splicing mechanism was disrupted, resulting in expression of only SERCA2b in the heart (SKO mice) (28) . SKO mice exhibited mild left ventricular hypertrophy and minor cardiac dysfunction but a dramatic reduction in SERCA levels and increased PLB expression. To investigate whether alleviation of the increased PLB suppression of SERCA would improve cardiac function and prevent hypertrophy, SKO mice were crossed with PLB Ϫ/Ϫ mice (27) . Although double knockout (DKO) mice exhibited a high SERCA2 Ca 2ϩ affinity, total SERCA levels were further reduced to 30% of wild-type (WT) values and the mice developed severe hypertrophy, diastolic dysfunction, and reduced contractile reserve (27) . We presently examined the role of cardiomyocyte Ca 2ϩ handling in the functional defect, which could be related to a reduced capacity for SR Ca 2ϩ uptake. Reduced Ca 2ϩ removal capacity may also trigger the structural remodeling in DKO hearts through activation of Ca 2ϩ -dependent signaling pathways.
MATERIALS AND METHODS
Experiments were conducted with adult mice (age 10 -16 wk) of either sex in accordance with the Guide for the Care and Use of Laboratory Animals (National Institute of Health). Protocols for handling experimental animals were also approved by the ethical commission of KU Leuven. For analysis of RNA and protein expres-sion levels, hearts were rapidly excised and frozen. Ventricular homogenates were prepared as in (27) . Standard Western blotting techniques were employed (27) using polyclonal antibodies directed against calcineurin A␤ (CnA␤; Chemicon, Billerica, MA, USA) and monoclonal antibodies against the kinases of the mitogen-activated protein kinase (MAPK) pathway (total levels and phosphorylated levels): JNK, P-JNK, p39, P-p38, ERK, and P-ERK (Cell Signaling Technology, Beverly, MA). Ventricular total RNA was isolated as in Vangheluwe et al. (27) , and mRNA levels of modulatory calcineurininteracting protein 1.4 (MCIP1.4) and calcineurin A were determined by reverse transcription PCR. RNA was treated with DNase I, and cDNA was prepared from 1 g total RNA in 20 l reverse transcriptase buffer according to the manufacturer (Thermoscript; Invitrogen, Merelbeke, Belgium). Negative controls without reverse transcriptase were tested. The number of PCR cycles was chosen to fall in the exponential phase of amplification. Primers were as follows: MCIP1.4: forward primer, 5=-AAGGAACCTCCAGCTTGGGCT-3=, reverse primer, 5=-CCCTGGTCTCACTTTCGCTG-3=, Ta ϭ 54°C, fragment of 159 bp, 20 cycles; and calcineurin A: forward primer, 5=-CCA-CAGGGATGTTGCCTAGTG-3=, reverse primer, 5=-GTCCCGTG-GTTCTCAGTGGTA-3=, Ta ϭ 55°C, fragment of 244 bp, 20 cycles.
Ventricular myocytes were enzymatically isolated as described previously (4) . Cells were stored at room temperature, and experiments were performed within 6 h of isolation. Myocytes were plated in an open-perfusion chamber mounted on the stage of an inverted microscope. Cell contractions were recorded with a video-edge detector (Crescent, Salt Lake City, UT) at a 240-Hz frame rate, and data are presented as fractional shortening (%diastolic length Basic characterization of cellular contractions, Ca 2ϩ transients, and the frequency response was performed during perfusion with a modified Tyrode solution (in mmol/l: 137 NaCl, 5.4 KCl, 0.5 MgCl2 , 1.0 CaCl 2, 11.8 Na-HEPES, and 10 glucose, pH 7.4). Myocytes were either field stimulated (1-Hz, 5-ms square pulses, 37°C) or studied in whole cell voltage clamp mode (30°C). The pipette solution contained the following (in mmol/l): 120 K-aspartate, 20 KCl, 10 K-HEPES, 5 MgATP, 10 NaCl, and 0.05 K5-fluo-3, pH 7.2. The voltage-clamp protocol in these experiments consisted of 25-ms voltage steps from Ϫ70 to ϩ20 mV, given at a range of frequencies. The effects of 10 M forskolin (Sigma-Aldrich, Bornem, Belgium) treatment were examined in some experiments.
Membrane currents were sampled at 4 kHz and filtered at 2 kHz. For measurement of L-type Ca 2ϩ current (ICaL), K ϩ currents were blocked by replacing K ϩ with Cs ϩ . The external solution contained the following (in mmol/l): 130 NaCl, 10 CsCl, 0.5 MgCl2, 1.0 CaCl2, 11 Na-HEPES, and 10 glucose, pH 7.4, 22°C. The pipette solution contained the following (in mmol/l): 120 Cs-aspartate, 10 TEACl, 10 Cs-HEPES, 0.5 MgCl2, 5 MgATP, and K5-fluo-3, pH 7.2. The voltage-clamp protocol consisted of a 250-ms prepulse from Ϫ70 mV to Ϫ45 mV, followed by a series of 250-ms depolarizing voltage steps ranging between Ϫ45 mV and ϩ65 mV. Cellular capacitance was measured during a voltage step from Ϫ70 mV to Ϫ80 mV.
To measure releasable SR Ca 2ϩ content, a train of 10 conditioning pulses (1 Hz, Ϫ70 to ϩ20 mV) was used to induce stable SR loading, after which cells were clamped at Ϫ70 mV and rapidly perfused with 10 mmol/l caffeine. SR content was estimated by measuring the magnitude of the caffeine-elicited Ca 2ϩ transient and by integrating the caffeine-induced Na ϩ -Ca 2ϩ -exchange (NCX) current. Elevated Ca 2ϩ loads were induced by blocking Ca 2ϩ extrusion via the Na ϩ -Ca 2ϩ exchanger as described previously (4) . The pipette solution in these experiments contained the following (in mmol/l): 120 Cs-aspartate, 10 TEACl, 10 Cs-HEPES, 0.5 MgCl2, 5 MgATP, and 0.05 K5-fluo-3, pH 7.2. After the SR was depleted with a rapid caffeine application, cells were exposed to a Na ϩ -free solution (in mmol/l: 120 NMDGCl, 20 TEACl, 11 HEPES, 0.5 MgCl2, 5.4 CaCl2, and 10 glucose, pH 7.4, 22°C) during 0.25-Hz stimulation with 100-ms voltage steps from Ϫ70 to 0 mV.
Statistical analyses were performed using SigmaPlot and SigmaStat software, and statistical significance (P Ͻ 0.05) was determined by paired or unpaired Student t-tests. Data are displayed as mean values Ϯ SE.
RESULTS

Ca
2ϩ -dependent hypertrophy signaling pathways are activated in DKO. We (27) have previously observed modest concentric hypertrophy in SKO hearts that was exacerbated in DKO (Fig. 1A) . For insight into the signaling pathways underlying hypertrophy in these mice, we here examined the calcineurin-nuclear factor of activated T-cell (NFAT) system, as this pathway is both required and sufficient for hypertrophic signaling (29) . This was done by measuring the NFAT-dependent transcription activation of MCIP1.4, which, as an endogenous reporter for calcineurin activity, contains multiple NFAT binding sites in an internal promoter (32) . MCIP1.4 mRNA levels (Fig. 1, B and C) were increased by approximately twoand threefold in SKO and DKO, respectively, correlating well with the degree of hypertrophy observed in these mice. Cal- Fig. 1 . Hypertrophy in single and double knockout (SKO and DKO) hearts is correlated with activation of Ca 2ϩ -dependent hypertrophic signaling pathways. Mild concentric hypertrophy was observed in SKO hearts, and was exacerbated in DKO, as was shown before in (25) (A). The degree of hypertrophy was correlated with modulatory calcineurin interacting protein 1.4 (MCIP1.4) transcription (B and C), an endogenous reporter for calcineurin-nuclear factor of activated T-cell activation. Calcineurin mRNA levels were unaltered in SKO and DKO. CnA␤, calcineurin A␤. nhearts ϭ 4, 3, and 5 in wild-type (WT), SKO, and DKO, respectively; *P Ͻ 0.05 vs. WT. cineurin mRNA levels were unaltered (Fig. 1, B and C) , as were the ratios between phosphorylated and unphosphorylated JNK, ERK, and p38 (Supplemental Fig. S1 ; Supplemental Material for this article is available online at the Am J Physiol Heart Circ Physiol website), i.e., components of the MAP kinase signaling pathway. These data indicate an involvement of Ca 2ϩ -dependent (calcineurin-NFAT) but not MAP kinase signaling pathways in SKO and DKO remodeling.
Myocyte contraction and relaxation are improved in DKO. Because the extent of hypertrophy in SKO and DKO correlates with calcineurin activation, we explored WT, SKO, and DKO myocytes for altered Ca 2ϩ signaling. Representative recordings of myocyte contractions and Ca 2ϩ transients are shown in Fig. 2, A and B, respectively. Mean systolic cell shortening (Fig. 2C ) was significantly larger in DKO cells than in SKO. Relaxation tended to be slower in SKO than in WT, as indicated by larger tau values, but was significantly faster in DKO (Fig. 2D) . Ca 2ϩ transients were of similar amplitude in WT, SKO, and DKO (Fig. 2E) , and Ca 2ϩ decayed more rapidly in DKO than either WT or SKO (Fig. 2F) . Thus cytosolic Ca 2ϩ transient amplitude and kinetics did not predict the degree of activation of Ca 2ϩ -dependent signaling pathways in the three groups (Fig. 1) . Altered Ca 2ϩ homeostasis could also not explain diastolic dysfunction observed in vivo (27) .
The rapid decline of Ca 2ϩ transients in DKO is surprising given the extremely low SERCA expression levels (30% of WT). We therefore examined the possibility that an increased rate of Ca 2ϩ removal by other pathways might be a contributing factor. Patch-clamped cells were stimulated with a train of voltage steps (Ϫ70 to ϩ20 mV) at 1 Hz, followed by rapid application of caffeine (Fig. 3A) . Ca 2ϩ declined more slowly in DKO than WT during caffeine application (Fig. 3, A and B) . (Fig. 3C) . Such slowing of Ca 2ϩ removal could theoretically result from a reduced rate of mitochondrial Ca 2ϩ uptake; however, there is controversy concerning the kinetics of Ca 2ϩ removal by this pathway (18) . Another possibility is reduced Ca 2ϩ extrusion by the plasmalemmal Ca 2ϩ ATPase (PMCA). Although we (27) have previously reported no alterations in PMCA expression in DKO, it is possible activity is nevertheless reduced. We conclude that the rapid decline of Ca 2ϩ transients in DKO must result from markedly enhanced SR Ca 2ϩ reuptake, presumably due to the high affinity of SERCA2b and absence of PLB.
SR content and release are normal in DKO. Ca 2ϩ transients elicited by voltage steps at 1 Hz were of similar magnitude in DKO cells as in WT, as illustrated by representative examples (Fig. 3A) and mean data (Fig. 4A) . SR content was also similar in WT and DKO, as assessed by the magnitude of the caffeineelicited Ca 2ϩ transient (Figs. 3A and 4B ) and integrated NCX current (Fig. 4C) . The trigger for SR Ca 2ϩ release, I CaL , was of comparable magnitude and voltage dependence in WT and DKO (Fig. 4D) . Thus, at low pacing rates, global Ca 2ϩ homeostasis was not impaired in DKO and could not account for structural and functional remodeling observed in vivo. Ca 2ϩ cycling is preserved at high pacing rates. In addition to exhibiting functional deficits at baseline, DKO mice also show impaired cardiac reserve (27) . An important component of cardiac contractile reserve is an ability of myocytes to enhance SR Ca 2ϩ reuptake as the stimulation frequency and cytosolic Ca 2ϩ load increase. We therefore examined SR Ca 2ϩ uptake under these two conditions. We first tested the frequency response by stimulating myocytes with 25-ms voltage steps from Ϫ70 to ϩ20 mV at different frequencies. Additionally, each stimulus train was followed by a 1-s pause and then a test pulse to assess SR Ca 2ϩ release with I CaL fully recovered (Fig. 5A) (3) . Increasing stimulation frequency increased diastolic [Ca 2ϩ ] i in WT, but, interestingly, diastolic values were not significantly elevated in DKO (Fig. 5B) . At low frequencies, the rate of Ca 2ϩ decay was faster in DKO than WT, but frequency-dependent acceleration of Ca 2ϩ decline only occurred in WT. Thus, at 8 Hz, time to half decay was similar in the two groups (Fig. 5C ). These findings indicate that at physiological stimulation frequency diastolic Ca 2ϩ homeostasis is not impaired in DKO despite a 70% reduction in SERCA levels. Both WT and DKO exhibited a decline in the amplitude of Ca 2ϩ transients as frequency increased (Fig. 5D ). This is likely due to I CaL inactivation (3), since the amplitude of test pulses applied after a 1-s pause (to allow I CaL recovery) was maintained in DKO and tended to increase in WT (Fig. 5E ). In agreement with this observation, caffeine applications administered at the end of the stimulus train indicated increasing SR load with frequency in WT and maintained SR load in DKO (Fig. 5F) (Fig. 6B) . By comparison, we have previously observed that SKO cells exposed to this protocol exhibit impaired Ca 2ϩ reuptake as Ca 2ϩ levels rise, presumably due to increased PLB expression (4). Thus, in the absence of phospholamban expression, the low level of SERCA2b in DKO myocytes can maintain efficient SR Ca 2ϩ reuptake even at elevated Ca 2ϩ load. This indicates that under these conditions the Ca 2ϩ affinity of SERCA is more important than the maximal turnover rate.
DISCUSSION
In the present study, we have demonstrated that myocytes in which SERCA2a is replaced by the high affinity SERCA pump, SERCA2b, in the absence of PLB exhibit remarkably normal global Ca 2ϩ homeostasis. Despite the low SERCA levels in DKO, we observed rapid Ca 2ϩ reuptake even at high Ca 2ϩ loads and stimulation frequencies. The well-preserved Ca 2ϩ homeostasis in DKO was paradoxically associated with marked activation of Ca 2ϩ -dependent signaling pathways. Comparison with in vivo cardiac function. Some observations of isolated cardiomyocyte function in DKO are consistent with the in vivo phenotype of these mice. Ca 2ϩ transients were found to be of near-normal magnitude over a wide range of stimulation frequencies in DKO. In fact, at low stimulation frequencies SR Ca 2ϩ content, Ca 2ϩ transient magnitude, and contraction were observed to be slightly larger in DKO than in WT, although these trends did not reach statistical significance in all cases. These data support the in vivo finding of preserved load-independent systolic function (27) . However, in vivo diastolic function (assessed by dP/dt min ) and overall cardiac output are depressed in DKO (27) . This observation is at odds with observations made in cells where Ca 2ϩ reuptake is more rapid in DKO than WT at low stimulation frequencies and normal at physiological rates. Impaired diastolic function in the intact heart may instead result from an observed stiffening of the myocardium (27) . Although we have not observed fibrosis in DKO hearts (27) , other unknown alterations in the extracellular matrix could compromise tissue compliance. The geometric constraints of hypertrophy should also be considered, as wall thickening and reduction in chamber size during concentric hypertrophy can impair diastolic function (16). In the normal heart, an increase in heart rate elevates SR Ca 2ϩ content. This response is an important component of contractile reserve and believed to be largely mediated via phospholamban (36) . Indeed, we (27) previously observed impaired contractile reserve in DKO mice. We presently showed that although SR content did not significantly increase with frequency in DKO, releasable Ca 2ϩ levels were close to WT values. This observation suggests that alterations at the level of the cardiomyocyte likely only minorly contribute to impaired in vivo performance of the heart at high frequencies. Thus other limitations such as the remodeled myocardial geometry and possibly a reduced response to adrenergic stimulation may impair contractile reserve in DKO.
Data from a number of transgenic mouse models have suggested that the PLB-to-SERCA ratio is an important determinant of cardiac contractility and relaxation (21) . For example, cardiac-specific overexpression of PLB reduces contraction and relaxation both in vivo and in isolated cells (15) . Opposite effects have been observed in mice overexpressing SERCA (12) . However, it appears that the PLB-to-SERCA ratio may only be a good indicator of contractility and relaxation in a SERCA2a background. We observed that in vivo and isolated cardiomyocyte function were only mildly affected in SKO despite a fourfold increase in PLB to SERCA2b (4, 28) . Using mathematical modeling, we predicted that lower SERCA levels in these mice compensate for the presence of the high Ca 2ϩ affinity SERCA isoform to prevent excessive SR Ca 2ϩ uptake and abnormally low diastolic [Ca 2ϩ ] i (4) . When PLB is ablated, SERCA levels are further reduced, which, as indicated by our present findings, maintains Ca 2ϩ cycling in a normal range. Thus it appears that the Ca 2ϩ affinity of SERCA is tightly regulated within a narrow window to minimize defi- ciencies in Ca 2ϩ handling. In this regard, it appears that the Ca 2ϩ affinity of SERCA is more important than the expression level and maximal turnover rate.
Implications for hypertrophy signaling. It is intriguing that although we observed marked activation of the Ca 2ϩ -dependent NFAT-calcineurin signaling pathway in DKO, we could not detect alterations in global Ca 2ϩ homeostasis in cardiomyocytes. This finding suggests that local Ca 2ϩ signaling may be importantly modified in DKO. We observed that diastolic Ca 2ϩ levels are ϳ150 nM in DKO cells at physiological frequency (Fig. 5B) , and recent evidence based on Ca 2ϩ -dependent modulation of LTCC and NCX indicates that local Ca 2ϩ levels in the dyadic cleft normally reach extremely high levels during Ca 2ϩ release (10 -15 M) (1). Importantly, we (27) -dependent signaling molecules. Notably, the calcineurin-interacting protein calsarcin-2 couples calcineurin to ␣-actinin at the Z-line of the sarcomere, which might link calcineurin activation to local Ca 2ϩ changes in this region (10) . Therefore, while upregulation of PLB in SKO and downregulation of SERCA in DKO may be aimed at maintaining global Ca 2ϩ homeostasis and contractility, such alterations may inappropriately alter local Ca 2ϩ homeostasis and trigger hypertrophy signaling pathways. The role of local microdomains in Ca 2ϩ -dependent hypertrophic signaling is likewise supported by the finding that hypertrophy is triggered by overexpression of the ␤ 2a -subunit of the L-type Ca 2ϩ channel (5) but not by overexpression of the T-type Ca 2ϩ channel (13) . This differential effect has been attributed to distinct localization of these Ca 2ϩ channels, with L-type channels present in the T-tubules and T-type channels present exclusively in the surface sarcolemma.
An interesting comparison can be made between the DKO mouse and the recently described conditional SERCA KO mouse (2, 19) . Ablation of the Serca2 gene in adult mice does not result in cardiac hypertrophy despite a reduction in SERCA levels to below 5% of normal values (2, 19) . Based on our discussion above, one might have speculated that with such extremely low SERCA levels, the conditional SERCA KO mice would be even more prone to hypertrophy, which is not the case. However, two important differences between the SERCA KO and DKO mice should be considered. First, the conditional SERCA KO predominantly expresses SERCA2a (WT background), and second, Ca 2ϩ transient amplitude is reduced in these cells. Together, this may mean that remaining SERCA2a pumps are not easily saturated with Ca 2ϩ . Furthermore, SERCA KO myocytes exhibit an impressive upregulation of Ca 2ϩ extrusion pathways, including both NCX and non-NCX systems, which has been shown to maintain diastolic [Ca 2ϩ ] i at normal values (17, 19) . In DKO myocytes, on the other hand, the expression of NCX and PMCA are unaltered (27) , and we even observed a somewhat impaired non-NCX mediated Ca 2ϩ extrusion (Fig. 3) . Indeed, Wu et al. (31) have suggested that PMCA4b activity controls a sub-sarcolemmal Ca 2ϩ microdomain critical for calcineurin activation. Thus the hypertrophy signaling we observed in DKO could theoretically result from reduced extrusion from such a subsarcolemmal compartment.
Estimation of in vivo NFAT activity was accomplished by measuring MCIP1.4 expression since, with its 15 NFAT binding sites, this is a robust reporter of NFAT activity (32) . Since MCIP is endogenous, this approach is arguably better suited for measuring NFAT activity than alternative methods requiring exogenous introduction of NFAT-dependent reporter genes. Commercially available kits are also not well suited for studies such as ours since they only allow calcineurin activity to be assessed at a fixed in vitro Ca 2ϩ concentration. While hypertrophy signaling pathways were presently examined in tissue from animals not deliberately exposed to stress protocols, it remains possible that these animals are submitted to intermittent stress in the animal facility. Thus the question could be raised as to whether baseline or fluctuating catecholamine levels affect Ca 2ϩ signaling in DKO to an extent that hypertrophy pathways are triggered. It is certainly true that due to the absence of PLB in DKO myocytes, these cells would be unable to respond normally to ␤-adrenergic stimulation by increasing the affinity of SERCA for Ca 2ϩ . In this situation, stress-induced alterations such as enhanced Ltype Ca 2ϩ current could theoretically activate NFAT signaling. Our observation that DKO myocytes can efficiently handle large increases in Ca 2ϩ load (Fig. 6 ) argues against this possibility. However, to be sure that a poor stress response is not involved with NFAT signaling in DKO, future work may examine whether ␤-blockers protect against hypertrophy development in these animals. It would also be interesting to examine NFAT activity in isolated myocytes where confounding issues of animal stress levels can be ruled out.
Conclusions. Our findings demonstrate that in mice expressing the high affinity SERCA2b pump instead of SERCA2a, ablation of PLB rescues global cardiomyocyte Ca 2ϩ homeostasis but does not prevent activation of Ca 2ϩ -dependent growth signaling pathways. These observations suggest that important differences in local Ca 2ϩ homeostasis might occur in DKO, perhaps due to reduced microdomain Ca 2ϩ buffering by SERCA2b. Global Ca 2ϩ homeostasis can also not explain impaired in vivo diastolic function in DKO, suggesting that this deficit instead results from hypertrophy-associated geometric constraints and/or loss of myocardial compliance.
